111 (YI) Stock Price, News & Analysis

Company Overview

111, Inc. (NASDAQ: YI) is a China-based technology-enabled healthcare platform that connects consumers, healthcare providers, pharmacies and pharmaceutical companies. The company focuses on improving access to healthcare products and services through digital tools and an integrated online and offline operating model.

Its business activities include online retailing and distribution of prescription and over-the-counter medicines, health products, medical devices and other healthcare-related goods. Through its digital platforms, 111 also provides medication information, health-management resources and other services intended to support consumers and healthcare professionals.

111 serves customers and business partners primarily in China. The company was founded in 2010 and has developed operations spanning consumer healthcare, pharmaceutical distribution and technology services. Its platforms are designed to connect pharmaceutical manufacturers with hospitals, pharmacies, clinics and individual consumers across the Chinese healthcare market.

111, Inc. was co-founded by Junling Liu, who has served as the company’s chief executive officer. The company completed its initial public offering on the Nasdaq Stock Market in 2018.

Key Stats

• Today's Range: $3.15 to $3.16
• 50-Day Range: $3.09 to $3.91
• 52-Week Range: $2.48 to $11.17
• Volume: 5,549 shs
• Average Volume: 26,806 shs
• Market Capitalization: $28.53 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

111 Stock Analysis - MarketRank™

111 scored higher than 14% of companies evaluated by MarketBeat, and ranked 837th out of 882 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

111 has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

111 has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of 111 is -1.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of 111 is -1.99, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.22% of the float of 111 has been sold short.

Short Interest Ratio / Days to Cover

111 has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in 111 has recently increased by 11.79%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

111 does not currently pay a dividend.

Dividend Growth

111 does not have a long track record of dividend growth.

News and Social Media

• Score: 2.5 / 5
• News Sentiment: N/A

News Sentiment

111 has a news sentiment score of 1.05. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.40 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 1 news article for 111 this week, compared to 2 articles on an average week.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, 111 insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $14,782.00 in company stock.

Percentage Held by Insiders

43.90% of the stock of 111 is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

21.32% of the stock of 111 is held by institutions.

Company Calendar

• Last Earnings: 9/18/2026
• Today: 10/09/2026
• Next Earnings (Estimated): 11/26/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Distributors
• Current Symbol: NASDAQ:YI
• CIK: 1738906
• Web: ir.111.com.cn
• Phone: 862120536666
• Fax: N/A
• Employees: 1,063
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($1.60)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$9.65 million
• Net Margins: -1.01%
• Pretax Margin: -0.38%
• Return on Equity: N/A
• Return on Assets: -4.86%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.08
• Quick Ratio: 0.49

Sales & Book Value

• Annual Sales: $10.48 billion
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($11.74) per share
• Price / Book: -0.28

Miscellaneous

• Outstanding Shares: 8,785,000
• Free Float: 4,928,000
• Market Cap: $28.55 million
• Optionable: Optionable
• Beta: 0.67